Eau Thermale Avène Reinforces Sensitive Skin Authority with Derm Care For All

Expert Advice, Patient Solutions #DermCareForAll

PARSIPPANY, N.J., Feb. 13, 2025 /PRNewswire/ -- Pierre Fabre Laboratories, the world's second-largest dermo-cosmetics company is committed to improving the quality of life of those with sensitive skin disorders by making Eau Thermale Avene's scientific education and skincare widely available. To achieve this, they will focus on advancing skin care solutions by deepening consumer understanding, forging strong partnerships with skin care experts, and strategically expanding product distribution to provide access for all.

Avène's ability to deliver effective skincare solutions for sensitive skin is rooted in its French pharmaceutical heritage. Developed in France, the brand employs a multidisciplinary scientific approach by collaborating with researchers and dermatologists to study skin pathologies. This research yields patented active ingredients with proven results which have improved skin disorders for patients globally. And now, the brand is taking its commitment to sensitive skin to the next level by reinforcing its commitment to consumers with authenticity and impact.

Avène has selected a network of board-certified dermatologists as their Dermfluencer Council. This renowned group of dermatologists will share their expert advice at key retail locations, breaking down complex science into actionable everyday tips that demystify skincare for every consumer.

"Through the Dermfluencer Council, Avène is reinforcing its mission to improve skin health by ensuring consumers have direct access to expert skincare advice and products —something that is crucial for navigating today's complex skincare landscape," said Lisa Morris, President and CEO of Pierre Fabre USA.

Meet the Dermfluencers
The inaugural Dermfluencer Council includes 4 distinguished dermatologists, each serving as trusted retail partners for consumer education:

• Dr. Jarett Casale, DO, FAAD: A board-certified dermatologist and Mohs Surgery Fellow who is passionate about skin health and well-being, representing Avène at Walgreens.
• Dr. Jenny Liu, MD, FAAD: A board-certified dermatologist specializing in ethnic dermatology and medical education, representing Avène at CVS.
• Dr. Neera Nathan, MD, MSHS: A board-certified dermatologist and Mohs surgeon, representing Avène at Target.
• Dr. Lindsey Zubritsky, MD, FAAD: A board-certified dermatologist with expertise in pediatric and cosmetic dermatology representing Avène at Ulta Beauty. She partnered with the brand for their first retail collaboration at Ulta Beauty last year and will continue representing Avène.

As an addition to Avène's extensive retail distribution, the brand is launching its products in 1,388 Target stores across the United States—making their science-backed skincare solutions more accessible than ever before. This strategic retailer expansion significantly broadens the brand's reach and accessibility for guests with sensitive skin. "When you're dealing with a sensitive skin concern, finding the right products quickly can make all the difference. As our trusted dermatologist partners continue to help consumers navigate skincare solutions, we're committed to ensuring that Avène the #1 French Pharmacy derm-skincare brand is readily available across the United States," said Lisa Morris, President and CEO of Pierre Fabre USA.

This commitment to accessibility is further strengthened by Avène's close partnerships with healthcare professionals. One such partnership is with Aire Health, a leading dermatologist platform co-founded by Dr. Dhaval Bhanusali and Dr. Muneeb Shah. Avène is teaming up with AIRE to make sure that over 3,200 residents and dermatologists in their network have access to the brand's scientific education, clinical information and products. "We are thankful to partner with Avène, a derm-favorite brand rooted in science and innovation. It will be a benefit for both our dermatology colleagues and more importantly, our patients," said Dr. Dhaval Bhanusali.

These dermatologist collaborations and the Target retailer expansion are at the forefront of Avène's commitment to provide #DermCareForAll—and it's just the beginning. With each new step, Avène continues to break down barriers, offering expert-backed education and skincare solutions to all.

Save the Date: On March 12^th, Avène celebrates their first ever National Skin Barrier Day, a day that will shine a spotlight on skin health and the power of science-backed skincare, stay tuned!

For more information, follow @aveneusa on Instagram and TikTok or visit www.aveneusa.com.

Note: High-resolution images, interviews, and product samples are available upon request.

ABOUT EAU THERMALE AVÈNE
With over 275 years of expertise rooted in dermatology and hydrotherapy, Eau Thermale Avène by Pierre Fabre is a leading brand dedicated to managing sensitive skin disorders and is recommended by dermatologists worldwide. Formulated with dermatologist-grade ingredients, Avène offers a wide range of high-quality, efficacious solutions with proven results. As Pierre Fabre is dedicated to improving the quality of life for all skin types, dermatologists are involved from product concept, development, and testing, to create safe solutions for even the most sensitive skin. At the heart of every formula is Avène Thermal Spring Water, which is clinically proven to soothe, soften and calm the skin and all products are non-comedogenic.

ABOUT PIERRE FABRE LABORATORIES
Pierre Fabre Laboratories is the world's second-largest dermo-cosmetics company and one of Europe's leading pharmaceutical companies. Its portfolio includes several international brands and medical franchises such as Pierre Fabre Oncology, Pierre Fabre Dermatologie, Pierre Fabre Pharma Care, Eau Thermale Avène, Ducray, A-Derma, Klorane, René Furterer, Darrow, Meme Cosmetics, Naturactive, Elgydium, Inava and Arthrodont.

In 2023, Pierre Fabre Laboratories posted 2.83 billion euros in revenue, 70% of which came from international sales in 120 countries. Historically based in the southwest of France and manufacturing 95% of its products in France, Pierre Fabre Laboratories employs over 10,000 people worldwide. Its annual R&D budget amounts to nearly 200 million euros, of which about 50% is dedicated to targeted therapies in oncology and 40% to skin health and care solutions.

Pierre Fabre Laboratories' majority shareholder (86%) is the eponymous Foundation, which is recognized by the French government as being a public-interest foundation. This capital structure guarantees the company's independence and long-term vision. Dividends paid to the Pierre Fabre Foundation enables the latter to design and finance humanitarian healthcare-access programs in developing countries. Employees are the company's secondary shareholder, through an international employee shareholding plan.

Pierre Fabre Laboratories' sustainability policy has been assessed by the independent AFNOR Certification body and has been awarded the "Exemplary" level of its CSR label (ISO 26 000 standard for sustainable development). 

Media Contact:
Beach House PR
[email protected]

SOURCE Avène USA